Glenmark Life Sciences IPO Details

Glenmark Life Sciences Ltd, API Subsidiary Company of Glenmark Pharmaceuticals Ltd, has filed a draft red herring prospectus with the Securities and Exchange Board of India (SEBI) for an Initial Public Offer (IPO) to raise Rs 1,160 crore.

About the Company

Aditya Birla Sun Life AMC Ltd logo

Glenmark Life Sciences is a leading developer and manufacturer of select high value, non-commoditized Active Pharmaceutical Ingredients (APIs) in chronic therapeutic areas.

Company develop, manufacture and supply high quality Active Pharmaceutical Ingredients (APIs) to our partners globally.

IPO Details

Issue Type Book Built Issue
Issue Price ₹0 to ₹0
Issue Size ₹0 per share
Face Value ₹0 per share
Market Lot 0 Shares
Listing On NSE/BSE
Key Dates of IPO
Ipo Open On No Update
Ipo Closes On Na
Allotment Date Na
Refund Date Na
Credit To Demat Na
Listing Date Na

Financials of the Company

Quarter 9MFY-2021 FY-2020 FY-2019
Total Income 14,184.72 Cr 15,493.03 Cr 8,868.65 Cr
Total Expense 10,881.50 Cr 11,282.36 Cr 6,585.68 Cr
Profit/Loss 2,468.97 Cr 3,130.98 Cr 1,955.92 Cr

Lot Size

Apl Lot Shares Amount
Min 1 Lot 0 shares ₹0
Max 0 Lot 0 shares ₹0

Promoter Holding

Pre Issue 78%
Post Issue 0%

IPO Documents

DRHP 6.8MB

Company Contact Detail

GLENMARK LIFE SCIENCES LIMITED
Plot No. 170-172, Chandramouli Industrial Estate, Mohol Bazarpeth, Solapur 413 213, Maharashtra, India
Tel No.: +91 2189 234456
Website: www.glenmarklifesciences.com
Email: [email protected]

Registrar Detail

Kfin Technologies Private Limited
Selenium, Tower B, Plot No. - 31 and 32 Financial District Nanakramguda, Serilingampally Hyderabad, Rangareddi 500 032 Telangana, India

Tel: +91 40 6716 2222
E-mail: [email protected]
Website: www.kfintech.com

Lead Manager of IPO

Kotak Mahindra Capital
BofA Securities
Goldman Sachs Securities
DAM Capital
BOB Capital Market
SBI Capital Market

Frequently Asked Questions

  • Currently, there are no update about the issue price of Glenmark Lifescience ipo.

  • Issue size of Glenmark Lifescience ipo is Rs.0 crore.
  • No Update.
  • No Update.
  • No Update.
  • No Update.
  • Kfin Technologies Private Ltd is the Registrar of Glenmark Lifescience ipo.
  • There are 6 Lead managers of this ipo.

    Kotak Mahindra Capital
    BofA Securities
    Goldman Sachs Securities
    DAM Capital
    BOB Capital Market
    SBI Capital Market

Conclusion

Hey, thank for reading this article.

Feel free to share your thoughts and questions in comment.

Don't forget to share it with your friends, family and colleagues.